NO20070146L - 4-fenylpyrimidin-2-karbonitril-derivater - Google Patents

4-fenylpyrimidin-2-karbonitril-derivater

Info

Publication number
NO20070146L
NO20070146L NO20070146A NO20070146A NO20070146L NO 20070146 L NO20070146 L NO 20070146L NO 20070146 A NO20070146 A NO 20070146A NO 20070146 A NO20070146 A NO 20070146A NO 20070146 L NO20070146 L NO 20070146L
Authority
NO
Norway
Prior art keywords
phenylpyrimidine
derivatives
carbonitrile derivatives
relates
carbonitrile
Prior art date
Application number
NO20070146A
Other languages
English (en)
Norwegian (no)
Inventor
Jiaqiang Cai
Zoran Rankovic
Jennifer Helen Moir
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of NO20070146L publication Critical patent/NO20070146L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20070146A 2004-06-11 2007-01-09 4-fenylpyrimidin-2-karbonitril-derivater NO20070146L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04253491 2004-06-11
EP04106949 2004-12-23
PCT/EP2005/006266 WO2005121106A1 (fr) 2004-06-11 2005-06-09 Derives 4-phenyle-pyrimidine-2-carbonitrile

Publications (1)

Publication Number Publication Date
NO20070146L true NO20070146L (no) 2007-02-02

Family

ID=34972893

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070146A NO20070146L (no) 2004-06-11 2007-01-09 4-fenylpyrimidin-2-karbonitril-derivater

Country Status (27)

Country Link
US (1) US7589095B2 (fr)
EP (1) EP1758870B1 (fr)
JP (1) JP2008501764A (fr)
KR (1) KR20070043779A (fr)
CN (1) CN1980897A (fr)
AR (1) AR053303A1 (fr)
AT (1) ATE404542T1 (fr)
AU (1) AU2005251923A1 (fr)
BR (1) BRPI0511951A (fr)
CA (1) CA2567845A1 (fr)
DE (1) DE602005008960D1 (fr)
DK (1) DK1758870T3 (fr)
EC (1) ECSP067074A (fr)
ES (1) ES2313380T3 (fr)
HK (1) HK1100002A1 (fr)
IL (1) IL179444A0 (fr)
MX (1) MXPA06014423A (fr)
MY (1) MY140123A (fr)
NO (1) NO20070146L (fr)
NZ (1) NZ551772A (fr)
PE (1) PE20060432A1 (fr)
PL (1) PL1758870T3 (fr)
PT (1) PT1758870E (fr)
RS (1) RS20060662A (fr)
RU (1) RU2382773C2 (fr)
TW (1) TW200614993A (fr)
WO (1) WO2005121106A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1901747A2 (fr) * 2005-05-25 2008-03-26 Ingenium Pharmaceuticals AG Inhibiteurs du cdk bases sur des pyrimidines destines au traitement de la douleur
AU2007267593B2 (en) * 2006-05-26 2013-04-04 University Of Louisville Research Foundation, Inc. Macrophage migration inhibitory factor antagonists and methods of using same
WO2008129080A1 (fr) 2007-04-24 2008-10-30 Ingenium Pharmaceuticals Gmbh Inhibiteurs de protéine kinases
KR100936278B1 (ko) * 2007-12-14 2010-01-13 한국생명공학연구원 단백질 포스파타제의 활성을 억제하는 피리미딘 유도체또는 이의 약학적으로 허용가능한 염을 유효성분으로함유하는 암 예방 및 치료용 조성물
BRPI0912029A2 (pt) * 2008-02-01 2020-06-30 Orchid Research Laboratories Limited novos heterociclos
WO2011038234A2 (fr) 2009-09-24 2011-03-31 University Of Louisville Research Foundation, Inc. Nouveaux dérivés d'iodo pyrimidines utiles pour le traitement de maladies ou affections liées au facteur inhibiteur de la migration des macrophages
US9155790B2 (en) 2010-05-20 2015-10-13 University of Lousiville Research Foundation, Inc. Methods and compositions for modulating ocular damage
BR112014008222A2 (pt) 2011-10-06 2017-04-25 Bayer Intelectual Property Gmbh heterociclilpiri (mi) dinilpirazol
MX355055B (es) 2012-04-17 2018-04-03 Astellas Pharma Inc Compuesto heterociclico aromatico biciclico nitrogenado.
CN104211645B (zh) * 2014-08-12 2016-08-24 武汉珈瑜科技有限公司 嘧啶类衍生物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO890521L (no) * 1988-02-25 1989-08-28 Bayer Ag Substituerte pyrimidiner.
DOP2002000328A (es) * 2001-02-14 2003-08-30 Warner Lambert Co Pirimidinas inhibidoras de metaloproteinasas de matriz
GB0121033D0 (en) 2001-08-30 2001-10-24 Novartis Ag Organic compounds
AR036375A1 (es) 2001-08-30 2004-09-01 Novartis Ag Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos
US20030144234A1 (en) 2001-08-30 2003-07-31 Buxton Francis Paul Methods for the treatment of chronic pain and compositions therefor
SE0201980D0 (sv) 2002-06-24 2002-06-24 Astrazeneca Ab Novel compounds
SE0201976D0 (sv) * 2002-06-24 2002-06-24 Astrazeneca Ab Novel compounds
GB0220187D0 (en) * 2002-08-30 2002-10-09 Novartis Ag Organic compounds
US7326715B2 (en) * 2005-09-23 2008-02-05 N.V. Organon 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives

Also Published As

Publication number Publication date
NZ551772A (en) 2009-05-31
JP2008501764A (ja) 2008-01-24
AR053303A1 (es) 2007-05-02
IL179444A0 (en) 2007-05-15
ATE404542T1 (de) 2008-08-15
US20080090813A1 (en) 2008-04-17
BRPI0511951A (pt) 2008-01-29
ECSP067074A (es) 2007-01-26
US7589095B2 (en) 2009-09-15
CN1980897A (zh) 2007-06-13
RS20060662A (en) 2008-09-29
MY140123A (en) 2009-11-30
EP1758870A1 (fr) 2007-03-07
MXPA06014423A (es) 2007-02-19
PT1758870E (pt) 2008-10-15
DK1758870T3 (da) 2008-10-20
RU2382773C2 (ru) 2010-02-27
ES2313380T3 (es) 2009-03-01
AU2005251923A1 (en) 2005-12-22
PE20060432A1 (es) 2006-06-23
PL1758870T3 (pl) 2009-01-30
WO2005121106A1 (fr) 2005-12-22
KR20070043779A (ko) 2007-04-25
TW200614993A (en) 2006-05-16
DE602005008960D1 (de) 2008-09-25
CA2567845A1 (fr) 2005-12-22
HK1100002A1 (en) 2007-08-31
RU2007101161A (ru) 2008-07-20
EP1758870B1 (fr) 2008-08-13

Similar Documents

Publication Publication Date Title
NO20070146L (no) 4-fenylpyrimidin-2-karbonitril-derivater
NO20082791L (no) 6-fenyl-1H-imidazo[4,5-C]-pyridin-4-karbonitrilderivater som Cathepsin K- og S-inhibitorer
WO2008042688A3 (fr) Inhibiteurs de co-transporteur 2 de sodium glucose et procédés d'utilisation de ceux-ci
NO20090321L (no) Anvendelse av substituerte 2-aminotyetraliner for produksjon av et medikament for forhindringen, lettingen og/eller behandlingen av diverse typer smerte
WO2012007868A3 (fr) Composés chimiques
WO2012007877A3 (fr) Composés chimiques
NO20062923L (no) Nye benzofuranderivater som kan anvendes i forebygging eller behandling av 5-HT6 reseptorrelatert forstyrrelse
NO20085100L (no) Nye forbindelser
NO20082124L (no) Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
PT2150530E (pt) Derivados de sulfonamida substituídos
NO20064078L (no) Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter
NO20082498L (no) Diarylurea for behandling av pulmonar hypertensjon
MX2010001236A (es) Derivados de 5-fenil-isoxazol-3-carboxamida como moduladores del receptor de potencial transitorio v1 (trpv1).
NO20071594L (no) Pyrimidinsulfonamidderivater som kjemokinreseptormodulatorer
DK1768748T3 (da) Sammensætninger omfattende strontium og vitamin D samt anvendelser deraf
WO2012048129A3 (fr) Inhibiteurs de kinase de type polo
WO2003053359A3 (fr) 1,3-bis-(phenyl-substitue)-2-propyne-1-ones et leur utilisation pour le traitement d'affections
WO2005037798A3 (fr) Nouveaux composés
WO2005082413A3 (fr) Combinaison de ciclesonide et de glycopyrronium
WO2008129501A3 (fr) Compositions pharmaceutiques de duloxetine
WO2009130422A3 (fr) N-acylthiourees et n-acylurees inhibiteurs de la voie de signalisation des proteines hedgehog
NO20075637L (no) 4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater som medikamenter for behandling av infertilitet
BR0105787A (pt) Composição farmacêutica, uso de um composto farmacêutico, método para tratamento de distúrbios, composto farmacêutico e método para confeccionar um composto farmacêutico
HRP20050603A2 (en) Novel anticonvulsant derivative salts
EA200970122A1 (ru) Фармацевтически приемлемые солевые и полиморфные формы малеата флюпиртина

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application